Current status and future outlook of artificial intelligence and automation in intravenous infusion systems.
- 1Faculty of Engineering and Technology, Egyptian Chinese University, Cairo, Egypt. [email protected].
- 2Faculty of Engineering and Technology, Egyptian Chinese University, Cairo, Egypt.
Abstract
The combination of the Internet of Things (IoT), artificial intelligence (AI), and wearable biosensors is transforming healthcare by allowing continuous, real-time monitoring and more intelligent clinical decision-making. This review explores AI-driven monitoring, smart intravenous (IV) infusion automation, and wearable biosensors, and proposes Intelligent IV Automation and Smart Patient Synchronization (INFUSYNC), a conceptual framework synchronizing monitoring, automated fluid delivery, and predictive analytics. The literature shows meaningful progress: wearables increasingly support non-contact monitoring with near clinical-grade accuracy for select parameters, while infusion pumps with dose-error-reduction and AI-assisted decision support are reported to improve delivery precision and safety. Predictive models further support early detection of physiological decline. Progress remains uneven, however: most AI-enabled infusion systems are prototype-stage, closed-loop control remains rare, and interoperability, data security, and privacy remain underdeveloped. Future systems will need compatible, security-by-design, clinically validated, feedback-controlled architectures. Overall, this review outlines a clear but early-stage trajectory toward integrated smart-health environments for IV therapy.
Related
- Automation and artificial intelligence in the clinical microbiology laboratory
- Artificial intelligence–assisted perioperative risk prediction, decision support, and supervised automation in anesthesia: A narrative review
- Toward integrated multimodal artificial intelligence in bone marrow examination: current state and open challenges
- Patient-Specific Implant Design: Current Evidence for Artificial Intelligence, Imaging and Computational Planning—A Systematic Review of the Biomedical-Indexed Literature
- Artificial Intelligence in Voice Disorders: Current Landscape, Emerging Applications and Future Directions
BibTeX
@article{ibrahim2026current,
title = {{Current status and future outlook of artificial intelligence and automation in intravenous infusion systems.}},
author = {Islam M Ibrahim and Rahma A Elkomy and Merna A Mohamed and Fatemah A Farok and Roaa E Emam and Salma A Kamel and Reham M Asem},
journal = {NPJ digital medicine},
year = {2026},
month = oct,
doi = {10.1038/s41746-026-03291-0},
url = {https://europepmc.org/article/MED/42875479},
note = {CC BY},
}
RIS
TY - JOUR
TI - Current status and future outlook of artificial intelligence and automation in intravenous infusion systems.
AU - Islam M Ibrahim
AU - Rahma A Elkomy
AU - Merna A Mohamed
AU - Fatemah A Farok
AU - Roaa E Emam
AU - Salma A Kamel
AU - Reham M Asem
PY - 2026
DA - 2026/10/14
JO - NPJ digital medicine
DO - 10.1038/s41746-026-03291-0
UR - https://europepmc.org/article/MED/42875479
AB - The combination of the Internet of Things (IoT), artificial intelligence (AI), and wearable biosensors is transforming healthcare by allowing continuous, real-time monitoring and more intelligent clinical decision-making. This review explores AI-driven monitoring, smart intravenous (IV) infusion automation, and wearable biosensors, and proposes Intelligent IV Automation and Smart Patient Synchronization (INFUSYNC), a conceptual framework synchronizing monitoring, automated fluid delivery, and predictive analytics. The literature shows meaningful progress: wearables increasingly support non-contact monitoring with near clinical-grade accuracy for select parameters, while infusion pumps with dose-error-reduction and AI-assisted decision support are reported to improve delivery precision and safety. Predictive models further support early detection of physiological decline. Progress remains uneven, however: most AI-enabled infusion systems are prototype-stage, closed-loop control remains rare, and interoperability, data security, and privacy remain underdeveloped. Future systems will need compatible, security-by-design, clinically validated, feedback-controlled architectures. Overall, this review outlines a clear but early-stage trajectory toward integrated smart-health environments for IV therapy.
SN - 2398-6352
ER -